EdgeMarketInstruments › GYRE

GYRE — GYRE THERAPEUTICS, INC.

US Healthcare Pharma & biotech equity mkt cap 782.8M
6.91 -1.57% today
USD · as of 2026-08-21

Price · 2024-08-26 → 2026-08-21

499 daily closes shown
52w low 5.56 · high 8.87

Anonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2017-02-13.

Performance

1 day-1.57%
1 week+3.44%
1 month+14.98%
3 months+11.81%
6 months-16.55%
Year to date+1.47%
1 year-10.61%
3 years+4.94%
5 years-88.76%

Technicals

RSI 1473.8
vs 50-day avg+8.24%
vs 200-day avg-4.03%
Volatility 1y58.2%
Max drawdown 1y-37.32%
Avg volume 30d55.1K
Daily bars held2,394
History from2017-02-13

Measured signals that fired on GYRE

datesignal measured base rate
2026-05-15Institutional holders jumped in a quarter
ownership
-0.52% over 21 days · t = -0.38 · n = 1,553
not distinguishable from its control group

Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →

Insider transactions (Form 4)

dateinsiderwhatshares pricevalue
2026-06-18Ye Weiguo
Chief Operating Officer
Open-market sale3.0K6.3519.1K
2026-06-18Ye Weiguo
Chief Operating Officer
Option exercise3.0K0.752.2K
2026-06-11Ye Weiguo
Chief Operating Officer
Open-market sale2.8K6.1717.3K
2026-06-11Ye Weiguo
Chief Operating Officer
Option exercise2.8K0.752.1K
2026-06-10Ye Weiguo
Chief Operating Officer
Open-market sale6.4K6.2139.9K
2026-06-10Ye Weiguo
Chief Operating Officer
Open-market sale5.0K6.2431.2K
2026-06-10Ye Weiguo
Chief Operating Officer
Option exercise6.4K0.754.8K
2026-06-10Ye Weiguo
Chief Operating Officer
Option exercise5.0K0.753.8K
2026-06-09Ye Weiguo
Chief Operating Officer
Open-market sale14.5K6.1489.0K
2026-06-09Ye Weiguo
Chief Operating Officer
Open-market sale3.0K6.1518.4K

Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →

Largest institutional holders

managervalueshares
VANGUARD CAPITAL MANAGEMENT LLC6.9M984.2K
BlackRock, Inc.5.3M758.6K
GEODE CAPITAL MANAGEMENT, LLC3.0M431.4K
STATE STREET CORP1.5M216.3K
SBI Securities Co., Ltd.1.2M170.8K
CHARLES SCHWAB INVESTMENT MANAGEMENT INC1.2M165.2K
VANGUARD FIDUCIARY TRUST CO959.6K137.7K
NORTHERN TRUST CORP932.9K133.8K
GOLDMAN SACHS GROUP INC509.7K73.1K
VANGUARD PORTFOLIO MANAGEMENT LLC486.6K69.8K

13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →

Latest SEC filings

formfiledperiod
10-Q2026-08-072026-06-30on EDGAR ↗
8-K2026-08-072026-08-07on EDGAR ↗
42026-08-042026-08-03on EDGAR ↗
42026-08-042026-08-03on EDGAR ↗
32026-08-042026-08-01on EDGAR ↗
32026-08-042026-08-01on EDGAR ↗
EFFECT2026-08-03on EDGAR ↗
8-K2026-07-162026-07-10on EDGAR ↗

Short selling

Avg short volume, 90d65.5% of tape
Days observed61

This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →

Ask the AI about GYRE

The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.

Open GYRE in the terminal → How the AI works

Everything on this page is live in the terminal.

Charts, filings, insider flow and the AI — open without an account.

Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →